Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fiberlock Technologies is a private U.S. manufacturer of environmental remediation, abatement, sanitation, and containment products used to address mold, lead, asbestos, disaster restoration, and indoor air quality challenges. The company sells high-performance coatings, cleaners, disinfectants, and mobile containment systems to professional restoration, abatement, and facility-management customers. Its offerings include legacy encapsulation products for asbestos and lead, EPA-registered mold remediation products, and containment solutions used in healthcare settings for patient isolation and particulate control. Fiberlock is part of ICP Group's Building Solutions Group and operates primarily as a commercial products company rather than a drug-development biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fiberlock Technologies.